By Our Bureau Comments READ LATER Drugmaker Cipla said the Konkan Division of the Food and Drugs Administration had ordered a suspension of the FDA licence to its manufacturing unit at Patalganga (Unit II) for 10 days in December 2023. The reason mentioned is non-conformance of good manufacturing practices under…Read More
Cipla Patalganga unit licence suspended for 10 days in December 2023
